Codex Panel Backs Use Of Observational Data To Support Health Claims
This article was originally published in The Tan Sheet
Executive Summary
Regulatory agencies worldwide should consider all available scientific evidence - including epidemiological and observational studies - when evaluating the basis of health claims for products marketed internationally, a Codex committee recommends